Walvax Biotechnology Market Cap

Walvax Biotechnology has a market cap or net worth of 18.86 billion as of March 9, 2026. Its market cap has decreased by -1.83% in one year.

Market Cap

18.86B

Enterprise Value

18.71B

Revenue

2.40B

Ranking

n/a

PE Ratio

382.91

Stock Price

11.79

Market Cap Chart

Since November 12, 2010, Walvax Biotechnology's market cap has increased from 13.63B to 18.86B, an increase of 38.29%. That is a compound annual growth rate of 2.14%.

Market Cap History

Date	Market Cap	% Change
Mar 6, 2026	18.68B	7.06%
Dec 31, 2025	17.45B	-9.69%
Dec 31, 2024	19.32B	-48.62%
Dec 29, 2023	37.60B	-41.50%
Dec 30, 2022	64.27B	-28.12%
Dec 31, 2021	89.42B	50.25%
Dec 31, 2020	Pro	Pro
Dec 31, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
China Resources Double-Crane Pharmaceutical	18.79B
Betta Pharmaceuticals	18.52B
Shandong Buchang Pharmaceuticals	17.63B
Tonghua Dongbao Pharmaceutical	17.57B
Wedge Industrial	19.89B
Zhejiang Medicine	17.42B
Apeloa Pharmaceutical Co.,Ltd	20.32B
Joincare Pharmaceutical Group Industry	20.47B

Market Cap Rankings